Introduction of New and Innovative Technologies to Improve Wound Care Management

Introduction of New and Innovative Technologies to Improve Wound Care Management

“The Future of the Wound Care Management Market to 2015”, report provides key data, information and analysis on the global wound care management market. The report provides market landscape, competitive landscape and market trends information on seven market categories including advanced wound management, compression therapy, ostomy drainage bags, traditional wound management, wound closure devices, negative pressure wound therapy and pressure relief devices. This report provides comprehensive information on the key trends affecting these categories, key analytical content and usage patterns on the market dynamics. The report also reviews the competitive landscape in terms of pipeline products and technology offerings. ( http://www.bharatbook.com/Market-Research-Reports/The-Future-of-the-Wound-Care-Management-Market-to-2015.html )

Wound Care Management Market to Cross billion by 2015

This report estimates that the global market for wound care management products, which was valued at around billion in 2008, would exceed billion by 2015 with a CAGR of 4%. The market is expected to be driven by the increasing number of surgeries and the rising prevalence of pressure ulcers, diabetic ulcers and venous ulcers. The market is also expected to be driven by technological advances and by the introduction of new and innovative therapies for wound care management. Also, increasing patient awareness is boosting the demand for wound care management. Patients are more proactive in their well being and are willing to seek physician’s advice at an early stage. Further, the availability of wide range of products to treat different kinds of wounds is increasing the acceptance of healthcare professionals.

US to Remain the Largest Market for Wound Care Management 

Globally, the US remains the largest wound care management market. The US market, valued at .2 billion in 2008, is forecast to grow by 4% annually for the next seven years to reach .5 million by 2015. The US, increasing its contribution from 39% to 43% towards the global wound care management market, is expected to remain the largest market for wound care management. The US wound care management market is expected to be driven by increasing prevalence of chronic wounds, better reimbursement levels for advanced technologies, positive demographics and increased levels of patient awareness.

Introduction of New and Innovative Technologies to Improve Wound Care Management

Introduction of new and innovative technologies are helping in meeting patient demands. Technologies such as electrical stimulation, electromagnetic therapy, nanotechnology, low level laser therapy, therapeutic ultrasound, nanocrystalline silver technology, nanospider technology and use of silver and combination dressings are improving wound care management. Other emerging trends in wound care management include tissue engineering, animal-fetal cell research for regenerating tissue in chronic wounds, stem cell therapy and gene therapy. Technological advances such as improvements in synthetic dressing materials are expected to have a positive impact on the growth in the wound care management market. Newer technologies such as recombinant growth factors, endovascular arterial repair techniques, bilayered human dermal substitutes and xenogeneic tissue scaffold are aimed at further improving the wound care management.

Advanced Wound Management and Wound Closure Devices are Key Categories in the Wound Care Management Market

Advanced wound management and wound closure devices categories accounted for 42% of the overall wound care management market in 2008. Advanced wound management market is driven by the rising prevalence of chronic wounds, increasing acceptance of the healthcare professionals and improving levels of patient awareness.  The

Aarkstore Enterprise -Advances in nanotechnology – Innovations in Oral Solid Drug Delivery: controlled formulations & peptide delivery-Aarkstore E

Aarkstore Enterprise -Advances in nanotechnology – Innovations in Oral Solid Drug Delivery: controlled formulations & peptide delivery-Aarkstore E

Innovations in Oral Solid Drug Delivery: Advances in nanotechnology, controlled formulations & peptide delivery

 
Table of Contents : 

Innovations in oral solid drug delivery
Executive summary 18
Market overview, dynamics and outlook 18
Advances in nanotechnology 19
Innovations in transitioning injectables to oral delivery 20
Advances in delayed & controlled release delivery 21
Advances in oral prodrug delivery 22
Advances in taste masking technologies 23
Innovative companies 24
Chapter 1 Market overview, dynamics and outlook 28
Summary 28
Market overview 29
Market dynamics 31
Key indications 33
Key trends 38
Nanomedicine 38
Transitioning from injectables 39
Prodrugs 40
Chrono release 41
ODT 41
OSF 42
Funding issues 42
Poor patient compliance 42
Injections 42
Poor absorbption 42
Pediatric 43
Geriatric 43
Solubility and variable absorption 43
Reduction of side effect profiles 44
Non-invasive protein delivery 45
Transition from injectables to preferred route of oral drug delivery 45
Directed delivery and delayed delivery to reduce side effect potential 46
Formulation technologies for poorly soluble compounds 46
Taste masking for pediatric and geriatric formulations 47
Competitive landscape 48
Conclusions and key findings 50
Chapter 2 Advances in nanotechnology 56
Summary 56
Introduction 57
Nanotechnology platforms with application for oral drug delivery 59
Self-Emulsifying Controlled Release Tablet system (SECRET) 59
Technology 59
Application 59
Biotransport nanomedicine technology 60
Technology 60
Application 60
Nanobodies 61
Technology 61
Application 61
NanoDel nanoparticles 62
Technology 62
Application 62
P-gpMask 63
Technology 63
Application 64
NanoDRY and NanoCOAT 64
Technology 64
Application 64
Solumer 67
Technology 67
Application 67
Nanocells 69
Technology 69
Application 70
Polymeric Nano-Delivery System (PNDS) 70
Technology 70
Application 71
FluidCrystal NP Oral nanoparticles 71
Technology 71
Application 72
CaP Technology and BioOral 72
Technology 72
Application 73
Nab Technology and Protospheres 73
Technology 73
Application 73
NanoCrystal Technology 74
Technology 74
Application 74
Bioral 75
Technology 75
Application 75
Squalenoyl nanoparticles 76
NanoMega 76
NOD Pharmaceutical 76
Chapter 3 Innovations in transitioning injectables to oral delivery 80
Summary 80
Introduction 81
Drivers 81
Patient acceptability & compliance 81
Cost savings 81
Restraints 82
Advances in injectable delivery 82
Challenges of oral drug delivery 83
Technologies used in oral drug delivery of peptides and proteins 84
Enzyme inhibitors 84
Permeation enhancers 85
Mucoadhesives 85
Encapsulation technologies 85
M-cell targeting 86
Competitive landscape 86
Osteoporosis and other bone related conditions 88
Calcitonin 88
Current therapies & market landscape 89
Oral products in development 91
Parathyroid hormone 94
Current therapies & market landscape 94
Oral products in development 96
Combined oral calcitonin and PTH approaches 97
Bisphosphonates 97
Current therapies & market landscape 97
Novel oral products in development 99
Diabetes and other metabolic diseases 104
Oral insulin 104
Oramed Pharmaceuticals 104
Biocon Ltd 105
Emisphere Technologies 105
Diabetology 106
NOD Pharmaceuticals 106
Access Pharmaceuticals 107
NanoMega Medical Corporation 107
Biodel Inc 108
Metabolic Pharmaceuticals Ltd

Incoming search terms:

• executive summary introduction to nanotechnology
• nanotechnology in oral drugs
• oral nanotechnolog introduction